Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-14
DOI
10.1038/s41375-018-0307-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
- (2018) Ondrej Hrusak et al. BLOOD
- Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
- (2018) David O’Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
- (2017) N Toft et al. LEUKEMIA
- Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
- (2017) Michaela Kotrova et al. Molecular Diagnosis & Therapy
- Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia
- (2017) Donald A. Berry et al. JAMA Oncology
- Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
- (2016) Prisca Theunissen et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy
- (2016) C-H Pui et al. LEUKEMIA
- Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial
- (2014) Josep-Maria Ribera et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia
- (2012) G. Gaipa et al. HAEMATOLOGICA
- Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
- (2012) R Garand et al. LEUKEMIA
- Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
- (2012) B Denys et al. LEUKEMIA
- Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
- (2011) M. Schrappe et al. BLOOD
- Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry
- (2011) Ingrid Thörn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
- (2011) M C Béné et al. LEUKEMIA
- Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
- (2010) V. Conter et al. BLOOD
- Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
- (2009) Giuseppe Basso et al. JOURNAL OF CLINICAL ONCOLOGY
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
- (2008) Jacqueline Ryan et al. BRITISH JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search